Technical Analysis for MAZE - Maze Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | N/A | N/A | N/A |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Gapped Down | Weakness | 0.00% | |
Hot IPO Pullback | Bullish Swing Setup | 2.92% | |
New 52 Week Low | Weakness | 2.92% | |
Gapped Down | Weakness | 2.92% | |
New 52 Week Closing Low | Bearish | 4.29% | |
Hot IPO Pullback | Bullish Swing Setup | 4.29% | |
New 52 Week Low | Weakness | 4.29% | |
Down 3 Days in a Row | Weakness | 4.29% | |
Gapped Down | Weakness | 4.29% | |
New 52 Week Closing Low | Bearish | 0.98% |
Alert | Time |
---|---|
Up 5% | 2 days ago |
Up 10% | 2 days ago |
60 Minute Opening Range Breakout | 2 days ago |
Up 3% | 2 days ago |
Gap Down Partially Closed | 2 days ago |
Get a Trading Assistant
- Earnings date: Unknown
Maze Therapeutics, Inc. Description
Maze Therapeutics, Inc. is a biotechnology company focused on translating genetic insights into new medicines. Founded in 2018 and based in South San Francisco, California, Maze leverages its proprietary COMPASS platform to systematically identify and validate genetic modifiers—genes that can alter the course of disease. By understanding these genetic interactions, Maze aims to develop novel therapies that can modulate disease pathways and provide significant clinical benefits. The company is particularly interested in addressing conditions with high unmet medical needs, utilizing a precision medicine approach to tailor treatments to individual genetic profiles. Maze Therapeutics is backed by a strong team of scientists and industry veterans, and it collaborates with various academic and industry partners to advance its research and development efforts.
Classification
Keywords: Biotechnology Disease Personalized Medicine
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 17.0 |
52 Week Low | 11.3416 |
Average Volume | 562,481 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 0.00 |
20-Day Moving Average | 0.00 |
10-Day Moving Average | 0.00 |
Average True Range | 0.00 |
RSI (14) | 0.00 |
ADX | 0.0 |
+DI | 0.00 |
-DI | 0.00 |
Chandelier Exit (Long, 3 ATRs) | N/A |
Chandelier Exit (Short, 3 ATRs) | N/A |
Upper Bollinger Bands | 0.00 |
Lower Bollinger Band | 0.00 |
Percent B (%b) | 0.0 |
BandWidth | 0.00 |
MACD Line | 0.00 |
MACD Signal Line | 0.00 |
MACD Histogram | 0.0 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 16.02 | ||||
Resistance 3 (R3) | 16.04 | 15.18 | 15.58 | ||
Resistance 2 (R2) | 15.18 | 14.51 | 15.17 | 15.43 | |
Resistance 1 (R1) | 14.28 | 14.09 | 14.73 | 14.26 | 15.29 |
Pivot Point | 13.42 | 13.42 | 13.65 | 13.41 | 13.42 |
Support 1 (S1) | 12.52 | 12.75 | 12.97 | 12.50 | 11.47 |
Support 2 (S2) | 11.66 | 12.33 | 11.65 | 11.33 | |
Support 3 (S3) | 10.76 | 11.66 | 11.18 | ||
Support 4 (S4) | 10.74 |